
A spot that does not heal or a growing nodule is a reason to see a dermatologist: most skin cancers are basal or squamous cell carcinomas, which in Germany are usually removed surgically, with the margins checked under the microscope.
Skin cancer treatment in Germany starts with one question: which tumour is it — basal cell carcinoma, squamous cell carcinoma or melanoma? The answer decides how much skin is removed and whether radiotherapy or drugs follow. Melanoma has its own page on melanoma treatment in Germany; this page covers the other two and their precursors.
Types of Skin Cancer and Who Treats Them in Germany
The main types are basal cell and squamous cell carcinoma, the non-melanoma skin cancers, treated in Germany mainly by dermato-oncologists. Basal cell carcinoma grows slowly and rarely spreads, but untreated it can invade cartilage and bone. Squamous cell carcinoma is more aggressive and may reach nearby lymph nodes; it can develop from actinic keratosis, a precancer: rough reddish patches on sun-damaged skin. Rare tumours such as Merkel cell carcinoma follow separate treatment pathways.
Dermato-oncologists at university skin hospitals work with surgeons, pathologists and radiation oncologists. The German Cancer Society (Deutsche Krebsgesellschaft) certifies such teams as skin cancer centres (Hautkrebszentrum), for example at the University Skin Hospital at Tuebingen University Hospital, the Skin Hospital at Erlangen University Hospital, the dermatology departments at Essen University Hospital and Charité Berlin. In Frankfurt the centre is at the Department of Dermatology at University Hospital Frankfurt, directed by Prof. Bastian Schilling.
Eczema, psoriasis or a harmless mole are a matter for general dermatology in Germany.
How the Diagnosis Is Made
Diagnosis takes two steps: an examination with a dermatoscope, an illuminated magnifier, and then histology. Digital dermoscopy stores the images, and body mapping photographs the whole skin so that changes show up at the next visit; more on skin cancer diagnostics.
A suspicious lesion is biopsied: a small one is often removed completely, a larger one sampled with a small round punch. The pathologist determines the tumour type and depth, using immunohistochemistry in difficult cases. Lymph node ultrasound, CT or MRI are needed only if deep growth or spread is suspected.
Surgery and Mohs Micrographic Surgery
Surgery is the main treatment: the tumour is cut out with a margin of healthy skin, and the edges are checked under the microscope. The margin is narrow for a small, well-defined basal cell carcinoma and wider for high-risk tumours; if tumour cells reach the edge, the area is re-excised.
Mohs surgery is chosen where every millimetre counts: on the face, including the eyelids, nose, lips and ears, for poorly defined borders and for recurrences. The tumour is removed in thin, mapped layers whose margins are examined at once on frozen sections; more tissue is taken only where tumour cells remain. In Germany a related approach is common: the margins are examined on standard, not frozen, sections, and the result usually arrives within one to two days. The wound stays dressed until the margins are clear, which may mean an extra day for the patient.
Small wounds are stitched; otherwise the surgeon uses a local flap of neighbouring skin or a skin graft to preserve function and appearance.
When Surgery Is Not Enough: Radiotherapy and Drugs
Radiotherapy and drugs come in when surgery is impossible or incomplete, or the disease has spread. Radiotherapy suits older patients who cannot have surgery and cases of incomplete removal when re-operation is not possible; skin tumours are treated, for example, at the Radiotherapy Centre, Munich-Pasing.
Advanced basal cell carcinoma that cannot be operated on or irradiated is treated with Hedgehog pathway inhibitors, vismodegib or sonidegib, which block a growth signal permanently switched on in these tumour cells. Advanced squamous cell carcinoma is treated first with checkpoint immunotherapy, which releases a brake on the immune system. It does not work for everyone; more on cancer immunotherapy.
Actinic keratosis is treated with creams or gels, freezing with liquid nitrogen or photodynamic therapy, which coats the skin with a light-sensitive substance and then illuminates it. The options are compared in the German S3 guideline on actinic keratosis and cutaneous squamous cell carcinoma.
What Skin Cancer Treatment in Germany Costs
The price depends on the examinations and the treatment needed: surgery with margin control, reconstruction, a hospital stay and, for advanced tumours, radiotherapy or drugs.
| Item | Indicative cost |
|---|---|
| MRI of one region | around €800; €900–1,000 with contrast |
| CT | around €500; around €550 with contrast |
| Surgery, reconstruction, radiotherapy, drugs | per the hospital’s estimate |
Doctors’ fees follow the official Gebührenordnung für Ärzte (GOÄ), and the invoice lists each service line by line. Before you travel, the hospital prepares an estimate (Kostenvoranschlag). Removing a small tumour as an outpatient costs noticeably less than surgery with reconstruction or a course of immunotherapy; see also the cost of a medical examination in Germany.
Frequently asked questions
Can skin cancer be cured completely?
Usually yes, if basal cell or squamous cell carcinoma is found early: complete removal with clear margins is often all that is needed. Advanced squamous cell carcinoma or a neglected basal cell carcinoma is harder to treat, and the doctor assesses the outlook individually. Melanoma is a separate subject.
Do I need to stay in hospital for the operation?
Usually not: these tumours are mostly removed under local anaesthesia, often as outpatient surgery, so you go home the same day. A stay may be needed for large tumours, complex reconstruction or the German variant of Mohs surgery, while histology is awaited between stages. Radiotherapy is usually outpatient, too.
Is follow-up needed after treatment?
Yes. The risk of a new skin tumour is higher afterwards, so a dermatologist regularly examines the entire skin, adding lymph node ultrasound after high-risk squamous cell carcinoma. Between visits, sun protection and self-examination help: a new spot or a sore that does not heal is a reason to come earlier.
How AlenMed Arranges Skin Cancer Treatment in Germany
AlenMed handles everything between your first message and the appointment: we collect photos of the lesion, reports, histology and, if available, slides, translate the documents, pass them to a dermato-oncologist at a partner hospital and request an estimate before you travel.
We then issue the visa invitation, meet you at the airport, arrange transfers and bring an interpreter to your appointments. AlenMed’s office is in Munich; our partner hospitals are across Germany.
This page is for reference only and is not an offer. Prices are indicative: the final sum follows the hospital’s estimate, and the treatment is decided by the doctor after an in-person examination.
News on this topic
Tübingen researchers uncover mechanism of immune suppression during cancer cell death
Researchers at Universitätsklinikum Tübingen discovered that dying cancer cells release PGE2 to suppress immune response during ferroptosis, opening paths for combination therapy.
New single-cell lung cancer atlas LuCaS+ uses AI to predict metastasis risk
German researchers from LMU, Charité, and TU Berlin created the LuCaS+ single-cell atlas, using AI to predict lung cancer metastasis risk from archived tissue samples.
ForTra Funds Clinical Trials for Leukemia and Muscular Dystrophy
ForTra gGmbH provides four million euros to support clinical trials for acute myeloid leukemia and Duchenne muscular dystrophy in Germany.


